×

APFRTV 2026
Event date: 27 – 29 August
Venue: South Asian University, New Delhi

APFRTV Conference 2026

APFRTV 2026 – Asia-Pacific Forum on RNA Therapeutics and Vaccines
“Advancing RNA Science from Bench to Population Impact”
About the Conference
APFRTV 2026 is a multidisciplinary scientific forum bringing together researchers, clinicians, industry leaders, innovators, and policymakers from across the Asia-Pacific region. The conference focuses on advancing RNA vaccines and RNA therapeutics, while also embracing a broader landscape of next-generation vaccines, biologics, and translational health innovations.
The forum aims to bridge the gap between discovery and real-world application by fostering collaboration, knowledge exchange, and strategic partnerships. With a strong emphasis on the One Health approach, APFRTV 2026 will explore integrated solutions that address human, animal, and environmental health challenges.
Objectives
•Showcase advancements in RNA vaccines and RNA therapeutics
•Promote interdisciplinary collaboration across sectors
•Explore complementary vaccine platforms and emerging technologies
•Address translational pathways from bench to bedside
•Strengthen regional and global partnerships
Program Overview
Day 1 – Pre-Conference Workshops (27th August)
Theme: Capacity Building & Prevention
•RNA Vaccine Technologies
•Cancer Prevention & Screening
•Hands-on training and community outreach
Day 2 – Scientific Sessions (28th August)
Theme: RNA Science & Therapeutics
•RNA Vaccine Platforms
•RNA Therapeutics (Oncology, Infectious & Rare Diseases)
•Delivery Systems & Nanotechnology
•AI & Bioinformatics in RNA Design
•Translational Research
Day 3 – Integration & Impact (29th August)
Theme: Innovation, Policy & Population Health
•Next-Generation & Complementary Vaccine Platforms
•Manufacturing & Scale-Up
•Public Health, Policy & Vaccine Equity
•One Health & Zoonotic Diseases
•Academia–Industry–Policy Collaboration
Highlights
•Plenary lectures by global experts
•Interactive scientific sessions & panel discussions
•Startup Innovation Showcase & Pitch Session
•Industry exhibitions and networking opportunities
•Pre-conference hands-on workshops
•Cancer Awareness Marathon (29th August 2026)
Who Should Attend
•Researchers & Scientists
•Clinicians & Healthcare Professionals
•Biotech & Pharma Industry
•Startups & Innovators
•Public Health Experts
•Policymakers & Regulators
•Students & Early-career professionals
Why Attend
•Stay updated with the latest advances in RNA science and vaccines
•Connect with leading experts and organizations
•Explore collaboration, funding, and partnership opportunities
•Showcase your research, innovations, and technologies
•Contribute to advancing translational science and public health
Conference Focus
RNA vaccines and RNA therapeutics at the core, complemented by diverse vaccine platforms and emerging technologies to enhance translational impact and global health outcomes.
Get Involved
•Abstract Submission – Opening Soon
•Registration – Opening Soon
•Call for Startups & Exhibitors – Now Open / Coming Soon

Registration

Call for Abstracts – APFRTV 2026
Overview
The Asia-Pacific Forum on RNA Therapeutics and Vaccines (APFRTV 2026) invites researchers, clinicians, industry professionals, innovators, and students to submit abstracts showcasing original research, innovations, and case studies in RNA science, vaccines, and translational health.
The conference places RNA vaccines and RNA therapeutics at its core, while also welcoming contributions from complementary vaccine platforms, biologics, and emerging health technologies.
Abstract Topics Include
•RNA Vaccines (mRNA, saRNA, circular RNA)
•RNA Therapeutics (siRNA, miRNA, ASO, mRNA)
•Delivery Systems & Nanotechnology
•Translational Research & Clinical Development
•Next-Generation & Complementary Vaccine Platforms
•AI, Bioinformatics & Computational Biology
•Manufacturing, Scale-Up & Quality Control
•Public Health, Policy & Vaccine Equity
•One Health & Zoonotic Diseases
•Startup Innovation & Translational Research
•Biobanking, Sample Storage & Cold Chain Logistics
(biospecimen collection, processing, cryopreservation, RNA stability, vaccine storage, quality assurance, regulatory frameworks)
•Open Category: Emerging areas in RNA science and vaccines
Submission Categories
•Oral Presentation
•Poster Presentation
•Young Investigator Award
Guidelines for Submission
•Abstracts must be original and unpublished
•Word limit: 250–300 words
•Structured format: Background, Methods, Results, Conclusion
•All submissions will undergo peer review
•Selected abstracts will be assigned for oral or poster presentation
Important Dates
•Abstract Submission Opens: 1 May 2026
•Abstract Submission Deadline: 30 June 2026
•Notification of Acceptance: 15 July 2026
•Early Bird Registration Deadline: 31 July 2026
•Conference Dates: 27–29 August 2026
Awards
Selected abstracts will be considered for:
•Best Oral Presentation Award
•Best Poster Presentation Award
•Young Investigator Award

Awards

Pre-Conference Workshop – 1
Translational Training on RNA Vaccines: From Design to Deployment
Date: 27 August 2026
Format: Hands-on + Demonstration + Interactive Sessions
Seats: 30 Only
Overview
This focused pre-conference workshop is designed to provide participants with practical and translational insights into RNA vaccine technologies, covering the complete pathway from molecular design to real-world deployment.
The session integrates laboratory exposure, computational approaches, and public health perspectives, aligning with current priorities in vaccine research and implementation.
Key Learning Areas
1. Lab & Design (Translational Science)
•RNA vaccine design principles
•Bioinformatics approaches (antigen selection, codon optimization)
•RNA handling and RNAse-free techniques
•RNA quality assessment (QC concepts)
2. Storage & Deployment
•RNA stability and degradation challenges
•Cold chain requirements for vaccines
•Storage conditions and handling practices
•Overview of delivery systems (e.g., lipid nanoparticles)
3. Clinical & Public Health Integration
•Vaccine delivery and administration concepts
•Immunization logistics and cold chain systems
•Basics of vaccine safety monitoring (AEFI)
•Case-based discussion on COVID-19 RNA vaccine deployment
Workshop Format
•Guided hands-on exposure (selected modules)
•Demonstration-based learning
•Interactive discussions and case studies
Who Should Attend
•Medical students and clinicians
•Researchers and PhD scholars
•Biotechnology and life science professionals
•Public health practitioners
Learning Outcomes
Participants will:
•Gain exposure to RNA vaccine design and laboratory practices
•Understand the translational pathway from lab to clinic
•Develop insights into vaccine storage, logistics, and deployment
•Strengthen knowledge in emerging vaccine technologies
Certification: All participants will receive a certificate of participation upon completion of the workshop.
Why Attend
•Integrated lab-to-clinic learning experience
•Focus on real-world vaccine challenges
•Alignment with translational research and public health priorities
Pre-Conference Workshop – 2
Breast Cancer Screening & Awareness: Early Detection to Community Impact
Date: 27 August 2026
Format: Demonstration + Interactive Training + Community-Oriented Learning
Duration: 4 Hours – Seats: 30 Only
Overview
This workshop focuses on early detection and prevention of breast cancer, equipping participants with essential knowledge and practical skills in screening, awareness, and community engagement.
It emphasizes evidence-based screening practices and public health strategies to improve early diagnosis and outcomes.
Key Learning Areas
1. Breast Cancer Fundamentals
•Epidemiology and risk factors
•Importance of early detection
•Overview of screening pathways
2. Screening & Early Detection
•Breast Self-Examination (BSE) – technique and frequency
•Clinical Breast Examination (CBE) – principles
•Mammography: indications and guidelines
Includes demonstration-based training
3. Awareness & Community Outreach
•Designing effective awareness programs
•Addressing myths, stigma, and barriers
•Role of healthcare providers and NGOs
4. Public Health & Implementation
•Screening program models (urban vs rural)
•Referral pathways and follow-up systems
•Integration with national health programs
Workshop Format
•Demonstration-based learning (BSE/CBE concepts)
•Interactive sessions and case discussions
•Community engagement strategies
Who Should Attend
•Students
•Housewives and community members
•Volunteers and community health advocates
•Nursing staff and allied health professionals
•NGOs and community outreach workers
•Medical students and public health trainees
No prior medical knowledge is required—sessions are designed to be simple, practical, and community-oriented.
Learning Outcomes
Participants will:
•Understand breast cancer risk factors and screening methods
•Gain practical knowledge of early detection techniques
•Develop skills for community awareness and outreach
•Strengthen capacity in screening program implementation
Certification: All participants will receive a certificate of participation upon completion of the workshop.
Why Attend
•Focus on prevention and early detection
•Practical and community-oriented training
•Supports public health impact and awareness initiatives

Sponsorship

Walkathon

Author

sales.vividtechno@gmail.com